Skip to main content

ASPX News

Bluebird, Pacira Pharmaceuticals Excite Life Science Investors

These stocks have had a really good run, says Wedbush Securities, which is holding its annual health care investment conference in New York.

Teva Makes $40.1B Bid for Generic-Drug Rival Mylan, Proving Rumors Right

Israeli generic-drug giant Teva announces it aims to acquire competitor Mylan for $82 per share, or $40.1 billion.

Teva, Actavis, Other Generic Drugmakers May Be on Acquisition Trail

Mylan's deal to buy Perrigo is taking another potential target off the block.

Teva, Actavis, Other Giants Set to Battle for Generics Space

Teva, Actavis and other generics giants may start preying on each other.

George Soros Might Invest $1 Billion in Ukraine -- Here's Where Else He's Investing

George Soros said this week that he is ready to pour $1 billion in Ukraine. With a $24 billion personal fortune, he can certainly afford it.

Breaking News

Sticker Shock: Ford Lifts Price Tag on 2023 F-150 Lightning Pro, Again

Those waiting to get their hands on Ford's all-electric F-150 Lightning aren’t just going to have to wait longer. They’re going to have to pay more.

More Details Emerge About Universal Studios' Disney World Killer

Universal Studios has begun construction on Epic Universe, its third theme park planned for Florida.

Amazon Sends Chilly Signs About the Economy

The e-commerce giant has just made a decision that suggests the health of the economy is not improving.

Elon Musk Casts Uncertainty Around Tesla

The Tesla CEO has put his offer for Twitter back on the table. And as rich as he is, investors are worried.